These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 26327460

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Biological Variation and Reference Change Value Data for Serum Neuron-Specific Enolase in a Turkish Population.
    Matyar S, Goruroglu Ozturk O, Ziyanoglu Karacor E, Yuzbasioglu Ariyurek S, Sahin G, Kibar F, Yaman A, Inal T.
    J Clin Lab Anal; 2016 Nov; 30(6):1081-1085. PubMed ID: 27121140
    [Abstract] [Full Text] [Related]

  • 5. Reference intervals for gastrointestinal tumor markers (AFP, CEA, CA199 and CA724) in healthy adults of Han nationality in Chongqing by Roche ECLIA system.
    Yu H.
    Scand J Clin Lab Invest; 2019 Nov; 79(7):484-490. PubMed ID: 31599689
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Study on the value of tumor markers ProGRP, CYFRA21-1, NSE and CEA in the differential diagnosis of pleural effusion].
    Liu Y, Yu L, Lin J.
    Zhongguo Fei Ai Za Zhi; 2006 Jun 20; 9(3):273-6. PubMed ID: 21172161
    [Abstract] [Full Text] [Related]

  • 8. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
    Schneider J, Philipp M, Velcovsky HG, Morr H, Katz N.
    Anticancer Res; 2003 Jun 20; 23(2A):885-93. PubMed ID: 12820318
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM, Sauer-Eppel H, Bruzdziak TH.
    Anticancer Res; 2007 Jun 20; 27(4A):1911-5. PubMed ID: 17649794
    [Abstract] [Full Text] [Related]

  • 12. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.
    Li F, Li S, Wei L, Liang X, Zhang H, Liu J.
    Biomarkers; 2013 Nov 20; 18(7):632-7. PubMed ID: 24066812
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The diagnostic and prognostic value of ProGRP in lung cancer.
    Nisman B, Biran H, Ramu N, Heching N, Barak V, Peretz T.
    Anticancer Res; 2009 Nov 20; 29(11):4827-32. PubMed ID: 20032442
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Progastrin-releasing peptide: stability in plasma/serum and upper reference limit.
    Nordlund MS, Bjerner J, Warren DJ, Nustad K, Paus E.
    Tumour Biol; 2008 Nov 20; 29(3):204-10. PubMed ID: 18667845
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biological variation of cardiac myosin-binding protein C in healthy individuals.
    Alaour B, Omland T, Torsvik J, Kaier TE, Sylte MS, Strand H, Quraishi J, McGrath S, Williams L, Meex S, Redwood S, Marber M, Aakre KM.
    Clin Chem Lab Med; 2022 Mar 28; 60(4):576-583. PubMed ID: 34162037
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.